Impact of erdosteine on exacerbations in moderate COPD

被引：0
|
作者：
Calverley, P. M. A. [1 ]
Papi, A. [2 ]
Page, C. [3 ]
Rogliani, P. [4 ]
Dal Negro, R. [5 ]
Cazzola, M. [4 ]
Cicero, A. [6 ]
Wedzicha, W. [7 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] Univ Ferrara, Ferrara, Italy
[3] Kings Coll London, London, England
[4] Univ Rome, Rome, Italy
[5] Natl Ctr Resp Pharmacoecon, Verona, Italy
[6] Univ Bologna, Bologna, Italy
[7] Imperial Coll, Bologna, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4365
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4365
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Physical activity and exercise capacity in patients with moderate COPD exacerbations
    Alahmari, Ayedh D.
    Kowlessar, Beverly S.
    Patel, Anant R. C.
    Mackay, Alex J.
    Allinson, James P.
    Wedzicha, Jadwiga A.
    Donaldson, Gavin C.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 340 - 349
  • [22] Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations
    Saldias P, Fernando
    Diaz P, Orlando
    Dreyse D, Jorge
    Gaggero B, Aldo
    Sandoval A, Christian
    Lisboa B, Carmen
    REVISTA MEDICA DE CHILE, 2012, 140 (01) : 10 - 18
  • [23] The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
    Mittmann, N.
    Kuramoto, L.
    Seung, S. J.
    Haddon, J. M.
    Bradley-Kennedy, C.
    FitzGerald, J. M.
    RESPIRATORY MEDICINE, 2008, 102 (03) : 413 - 421
  • [24] InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
    Singh, Dave
    Criner, Gerard J.
    Dransfield, Mark T.
    Halpin, David M. G.
    Han, MeiLan K.
    Lange, Peter
    Lettis, Sally
    Lipson, David A.
    Mannino, David
    Martin, Neil
    Martinez, Fernando J.
    Miller, Bruce E.
    Wise, Robert
    Zhu, Chang-Qing
    Lomas, David
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [25] InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
    Dave Singh
    Gerard J. Criner
    Mark T. Dransfield
    David M. G. Halpin
    MeiLan K. Han
    Peter Lange
    Sally Lettis
    David A. Lipson
    David Mannino
    Neil Martin
    Fernando J. Martinez
    Bruce E. Miller
    Robert Wise
    Chang-Qing Zhu
    David Lomas
    Respiratory Research, 22
  • [26] Impact Of Vilanterol, Fluticasone Furoate, Or Their Combination On Exacerbations In COPD Patients With Moderate Airflow Obstruction: The Summit Trial
    Martinez, F. J.
    Anderson, J.
    Brook, R.
    Celli, B.
    Crim, C.
    Kilbride, S.
    Newby, D.
    Vestbo, J.
    Yates, J.
    Calverley, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [27] Impact of nutritional state in acute exacerbations of COPD
    Kinder, Stephen S.
    Masel, Philip
    RESPIROLOGY, 2022, 27 : 128 - 128
  • [28] Impact of anxiety and depression on the prognosis of copd exacerbations
    Sandra, Martinez-Gestoso
    Maria-Teresa, Garcia-Sanz
    Jose-Martin, Carreira
    Francisco-Javier, Salgado
    Uxio, Calvo-Alvarez
    Liliana, Doval-Oubina
    Sandra, Camba-Matos
    Lorena, Peleteiro-Pedraza
    Miguel-Angel, Gonzalez-Perez
    Pedro, Penela-Penela
    Andres, Vilas-Iglesias
    Francisco-Javier, Gonzalez-Barcala
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [29] The impact of weekends on outcome for acute exacerbations of COPD
    Barba, R.
    Zapatero, A.
    Losa, J. E.
    Marco, J.
    Plaza, S.
    Rosado, C.
    Canora, J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (01) : 46 - 50
  • [30] Impact of anxiety and depression on the prognosis of copd exacerbations
    Sandra Martínez-Gestoso
    María-Teresa García-Sanz
    José-Martín Carreira
    Francisco-Javier Salgado
    Uxío Calvo-Álvarez
    Liliana Doval-Oubiña
    Sandra Camba-Matos
    Lorena Peleteiro-Pedraza
    Miguel-Angel González-Pérez
    Pedro Penela-Penela
    Andrés Vilas-Iglesias
    Francisco-Javier González-Barcala
    BMC Pulmonary Medicine, 22
12345